CR Ekkirala , P Cappello, R S Accolla, I Romero, C Garrido, AM Garcia-Lora, F Novelli. CLASS II TRANSACTIVATOR-INDUCED MHC CLASS II EXPRESSION IN
PANCREATIC CANCER CELLS LEADS TO TUMOR REJECTION AND A SPECIFIC ANTITUMOR MEMORY RESPONSE Pancreas 2014, in press
S. Rolla, G. Ingoglia, V. Bardina, L. Silengo, F. Altruda, F. Novelli
and E. Tolosano THE ACUTE-PHASE PROTEIN HEMOPEXIN IS A NEGATIVE REGULATOR OF TH17 RESPONSE AND EXPERIMENTAL AUTOIMMUNE ENCEPHALOMIELITIS DEVELOPMENT. The Journal of Immunology 2013 ;191 5451-9.
G Celesti, G Di Caro, P Bianchi, F Grizzi, F Marchesi, G Basso, D Rahal, G Delconte, M Catalano, P Cappello, M Roncalli, A Zerbi, M Montorsi, F Novelli, A Mantovani, P Allavena, A Malesci, L. Laghi. EARLY EXPRESSION OF THE FRACTALKINE RECEPTOR CX3CR1 IN PANCREATIC CARCINOGENESIS British Journal Cancer 2013 109:2424-33. ]
A Pessione, E Mangiapane C Lamberti, P Ceruti, F Novelli, E Galano, R Virkola, T Korhonen, E. Pessione., AN INTEGRATED PROTEOMIC AND PHYSIOLOGICAL APPROACH TO UNDERSTAND THE ADHESION MECHANISM OF THE PROBIOTIC LACTOBACILLUS REUTERI LB2 BM DSM16143. 2013 Journal of Integrated OMICS
M. Capello, P. Cappello, FC Linty, R. Chiarle, I. Sperduti, A. Novarino, P. Salacone, G. Mandili, A. Naccarati, C. Sacerdote, S. Beghelli, S. Bersani, S. Barbi, C.Bassi, A.Scarpa, P. Nisticò, M. Giovarelli, P. Vineis, M. Milella and F. Novelli AUTOANTIBODIES TO EZRIN ARE AN EARLY SIGN OF PANCREATIC CANCER IN HUMANS AND IN GENETICALLY ENGINEERED MOUSE MODELS. 2013 Journal of Hematology & Oncology 2013 ;6:67
A Amedei, E Niccolai, M Benagiano, C Della Bella, F Cianchi, L Bencini, M, Farsi, P. Cappello, D. Prisco, F Novelli , MM D'Elios. EX VIVO ANALYSIS OF PANCREATIC CANCER-INFILTRATING T LYMPHOCYTES REVEALS THAT ENO-SPECIFIC TREGS ACCUMULATE IN TUMOR TISSUE AND INHIBIT TH1/TH17 EFFECTOR CELL FUNCTIONS. Cancer Immunology Immunotherapy 2013 62:1249-60
M. Principe, P. Ceruti, M. Capello, P. Cappello, F. Novelli. THREE ARE ARE BETTER THAN ONE: PLASMINOGEN RECEPTOR AS CANCER THERANOSTIC TARGET. Experimental Hematology & Oncology, 2013, 17:212
P. Cappello, F Novelli. THE SELF-ANTIGEN ENO1 REOPENS GAMES IN PANCREATIC CANCER. OncoImmunology 2013 1;2(6):e24384
Pierobon D, Bosco MC, Blengio F, Raggi F, Eva A, Filippi M, Musso T, Novelli F, Cappello P, Varesio L, Giovarelli M. CHRONIC HYPOXIA REPROGRAMS HUMAN IMMATURE DENDRITIC CELLS BY INDUCING A PROINFLAMMATORY PHENOTYPE AND TREM-1 EXPRESSION. European Journal of Immunology. 2013;43:949-66.
W. Zhou, M. Capello, C. Fredolini, L. Racanicchi, E. Dugnani, L. Piemonti, L. A. Liotta, F. Novelli, and E. F. Petricoin. MASS SPECTROMETRY ANALYSIS REVEALS O-METHYLATION OF PYRUVATE KINASE FROM PANCREATIC CANCER CELLS", Analytical and Bioanalytical Chemistry, 2013;405:4937-43
P. Cappello, S. Rolla, R. Chiarle, M. Principe, F. Cavallo, G. Perconti, S. Feo, M. Giovarelli, F. Novelli. VACCINATION WITH ENO1-DNA PROLONGS SURVIVAL OF GENETICALLY ENGINEERED MICE WITH PANCREATIC CANCER, Gastroenterology, 2013;144:1098-106
MS Chiriacò, E. Primiceri, AG Monteduro, A Bove, S Leporatti, M Capello, S Ferri-Borgogno , R Ross, F Novelli, G Maruccio. TOWARDS PANCREATIC CANCER DIAGNOSIS BY EIS BIOCHIPS, Lab on Chip, 2013, 13 :730-4
M Bianco, , A Aloisi, V Arima, M Capello, S Ferri-Borgogno, F Novelli , S.Leporatti and R Rinaldi. QUARTZ CRYSTAL MICROBALANCE WITH DISSIPATION (QCM-D) AS TOOL TO EXPLOIT ANTIGEN-ANTIBODY INTERACTIONS IN PANCREATIC DUCTAL ADENOCARCINOMA DETECTION. Biosensors and Bioelectronics, 2013,;42:646-52
L, Avalle, S. Pensa, G. Regis, F. Novelli, V. Poli. STAT1 AND STAT3 IN TUMORIGENESIS: A MATTER OF BALANCE 2012 JAK-STAT 2013, 1:65-72
ZhouW, Capello M, Fredolini C, Racanicchi L , Piemonti L, Lotta LA, Novelli F, and Petricoin EFMASS SPECTROMETRY ANALYSIS REVEALS O-METHYLATION OF L-LACTATE DEHYDROGENASE FROM PANCREATIC DUCTAL ADENOCARCINOMA CELLS . Electrophoresis, 2012;33:1850-4
Conti L, De Palma R , Rolla S , Boselli D , Rodolico G , Kaur ,S Silvennoinen O, Niccolai E, Amedei A , Ivaldi F, Clerico M , Contessa G, Uccelli A , Durelli L, and Novelli F. TH17 CELLS IN MULTIPLE SCLEROSIS EXPRESS HIGHER LEVELS OF JAK2, WHICH INCREASES THEIR SURFACE EXPRESSION OF IFN-gammaR2. The Journal of Immunology 2012, 188:1011-8.
Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, LiottaLA, Novelli F and. Petricoin EF. PROTEOMIC ANALYSIS REVEALS WARBURG EFFECT AND ANOMALOUS METABOLISM OF GLUTAMINE IN PANCREATIC CANCER CELLS. Journal of Proteomics Research 2012 11:554-63.
Vaccaro V, Gelibter A, Bria E, Iapicca P, Cappello P, Di Modugno F, Pino MS,
Nuzzo C, Cognetti F, Novelli F, Nistico P, Milella M. MOLECULAR AND GENETIC BASES
OF PANCREATIC CANCER. Curr Drug Targets. 2012 Jun;13(6):731-43.
Zhou W, Capello M, Fredolini C, Racanicchi L, Piemonti L, LiottaLA., Novelli F and Petricoin EF. PHOSPHOPROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS DIFFERENTIAL PHOSPHORYLATION OF CELL ADHESION, CELL JUNCTION AND STRUCTURAL PROTEINS Journal of Proteomics & Bioinformatics 2011, 4:170-178
Zhou W, Capello M, Fredolini C, Piemonti L, Liotta LA, Novelli F, Petricoin. EF. PROTEOMIC ANALYSIS OF PANCREATIC DUCTAL ADENOCARCINOMA CELLS REVEALS METABOLIC ALTERATIONS. Journal Proteome Research. 2011;10:1944-52.
M. Capello, S. Ferri-Borgogno, P. Cappello, F. Novelli . a-ENOLASE: A PROMISING THERAPEUTICAL AND DIA
Tomaino B, Cappello P, Capello M, Fredolini C, Sperduti I, Migliorini P, Salacone P, Novarino A, Giacobino A, Ciuffreda L, Alessio M, Nisticò P, Scarpa A, Pederzoli P, Zhou W, Petricoin EF, Liotta LA, Giovarelli M, Milella M, Novelli F. CIRCULATING AUTOANTIBODIES TO PHOSPHORYLATED ALPHA-ENOLASE ARE A HALLMARK OF PANCREATIC CANCER. J Proteome Res. 2011;10:105-12
Fredolini C, Meani F, Luchini A, Zhou W, Russo P, Ross M, Patanarut A, Tamburro D, Gambara G, Ornstein D, Odicino F, Ragnoli M, Ravaggi A, Novelli F, Collura D, D'Urso L, Muto G, Belluco C, Pecorelli S, Liotta L, Petricoin EF 3rd. INVESTIGATION OF THE OVARIAN AND PROSTATE CANCER PEPTIDOME FOR CANDIDATE EARLY DETECTION MARKERS USING A NOVEL NANOPARTICLE BIOMARKER CAPTURE TECHNOLOGY. AAPS Journal. 2010;12:504-18.
Zhou, W; Capello M,; Fredolini C,; Piemonti L, Liotta L, Novelli F, Petricoin E. MASS SPECTROMETRY ANALYSIS OF THE POST-TRANSLATIONAL MODIFICATIONS OF ALPHA-ENOLASE FROM PANCREATIC DUCTAL ADENOCARCINOMA CELLS. Journal Proteome Research, 2010;9:2929-36
Boselli D, Ragimbeau J, Orlando L, Cappello P, Capello M, Ambrogio C, Chiarle R, Marsili G, Battistini A, Giovarelli M, Pellegrini S, Novelli F. EXPRESSION OF IFNGAMMAR2 MUTATED IN A DILEUCINE INTERNALIZATION MOTIF REINSTATES IFNGAMMA SIGNALING AND APOPTOSIS IN HUMAN T LYMPHOCYTES. Immunology Letters. 2010;134:17-25
G. Regis, L. Icardi, L. Conti, R. Chiarle, R. Piva, Mi. Giovarelli, V. Poli, and F. Novelli*. IN THE ABSENCE OF STAT3, IL-6 BUT NOT IFN- TRIGGERS APOPTOSIS AND INHIBITS IN VIVO GROWTH OF HUMAN MALIGNANT T CELLS. Leukemia 2009, 23:2102-2108
L. Durelli, L. Conti,M. Clerico, D. Boselli, G. Contessa, P Ripellino, B. Ferrero, P. Eid, and F. Novelli*. T HELPER 17 CELLS EXPAND IN MULTIPLE SCLEROSIS AND ARE INHIBITED BY INTERFERON-β. Annals of Neurology, 2009 , 65: 499-509.
P. Cappello, B Tomaino, R. Chiarle, A. Novarino, C. Castagnoli, P. Migliorini, G. Perconti, A. Giallongo, M. Milella, V. Monsurrò, S. Barbi, A. Scarpa, P. Nisticò, M. Giovarelli, F. Novelli*. AN INTEGRATED HUMORAL AND CELLULAR RESPONSE IS ELICITED IN PANCREATIC CANCER BY ALPHA-ENOLASE, A NOVEL PANCREATIC DUCTAL ADENOCARCINOMA ASSOCIATED ANTIGEN, International Journal of Cancer, 2009 125:639-48
C. Caorsi, P. Cappello, P. Ceruti, A. Amici, C. Marchini, F. Novelli, G. Forni and M. Giovarelli. CCL16 ENHANCES THE CD8+ and CD4+ T CELL REACTIVITY TO HUMAN HER-2 ELICITED BY DENDRITIC CELLS LOADED WITH RAT ORTHOLOG HER-2. International Journal of Immunopathology Pharmacology. 2008,21:867-77.
Elia AR, Cappello P, Puppo M, Fraone T, Vanni C, Eva A, Musso T, Novelli F, Varesio L, Giovarelli M. HUMAN DENDRITIC CELLS DIFFERENTIATED IN HYPOXIA DOWN-MODULATE ANTIGEN UPTAKE AND CHANGE THEIR CHEMOKINE EXPRESSION PROFILE. J Leukocyte Biology. 2008;84:1472-1482
G. Regis. S. Pensa D. Boselli F. Novelli, V. Poli. UPS AND DOWNS: the STAT1:STAT3 SEASAW GAME IN INTERFERON RECEPTORS AND gp130 SIGNALLING. Sem. Cell and Developmental Biology 19:351-9, 2008
S.Pensa, G. Regis, D. Boselli, F.Novelli e V. Poli. STAT1 AND STAT3 IN TUMORIGENESIS: TWO SIDES OF THE SAME COIN? In Jak-Stat Pathway in Disease, Edited by Anastasias Stephanou, Landes Bioscence, Chapter 8, 100-121, 2008
Valfre di Bonzo L, Ferrero I, Cravanzola C, Mareschi K, Rustichelli D, Novo E, Sanavio F, Cannito S, Zamara E, Bertero M, Davit A, Francica S, Novelli F, Colombatto S, Fagioli F, Parola. M. HUMAN MESENCHYMAL STEM CELLS AS A TWO-EDGED SWORD IN HEPATIC REGENERATIVE MEDICINE: ENGRAFTMENT AND HEPATOCYTE DIFFERENTIATION VERSUS PROFIBROGENIC POTENTIAL.Gut. 2008, 57:223-31
L. Conti, G. Regis, A. Longo, P. Bernabei, R. Chiarle, M. Giovarelli, and F. Novelli*. IN THE ABSENCE OF IGF-1 SIGNALING, IFN- SUPPRESSES HUMAN MALIGNANT T CELL GROWTH. Blood, 2007, 109:2496-2504
Boselli D, Losana G, Bernabei P, Bosisio D, Drysdale P, Kiessling R, Gaston JS, Lammas D, Casanova JL, Kumararatne DS, Novelli F*. IFN-gamma regulates Fas ligand expression in human CD4(+) T LYMPHOCYTES AND CONTROLS THEIR ANTI-MYCOBACTERIAL CYTOTOXIC FUNCTIONS. European Journal of Immunology 2007, 37:2196-204
B. Tomaino, P. Cappello, M. Capello, C. Fredolini, A. Ponzetto, A. Novarino, L. Ciuffreda, O. Bertetto, C. De Angelis, E. Gaia, M. Milella, P. Nisticò, M. Alessio, R. Chiarle, M.G. Giuffrida, M. Giovarelli, and F. Novelli. AUTOANTIBODY SIGNATURE IN HUMAN DUCTAL PANCREATIC ADENOCARCINOMA. Journal Proteome Research, 6:4025-31.2007
A. Puel, J. Reichenbach, J. Bustamante, C-L. Ku, J. Feinberg, R. Döffinger, M. Bonnet, O. Filipe Santos, L. de Beaucoudrey , A. Durandy, G. Horneff, F. Novelli, V. Wahn, A. Smahi , A. Israel, T. Niehues and J.-L. CasanovaTHE NEMO MUTATION CREATING THE MOST UPSTREAM PREMATURE STOP CODON IS HYPOMORPHIC OWING TO A RE-INITIATION OF TRANSLATION. American Journal of Human Genetics 2006, 78 :691-701.
G. Regis, L. Conti, D. Boselli and F. Novelli* IFNγR2 TRAFFICKING TUNES IFNγ/STAT1 SIGNALING IN T LYMPHOCYTES. Trends in Immunology, 2006, 27:96-101
P. Cappello,T. Fraone,L. Barberis,C. Costa,E. Hirsch,A.R. Elia,C. Caorsi, T. Musso,F. Novelli,and M Giovarelli. CC-CHEMOKINE LIGAND 16 (CCL16) INDUCES A NOVEL MATURATION PROGRAM IN HUMAN IMMATURE MONOCYTE-DERIVED DENDRITIC CELLS. Journal of Immunology 177:6143-6151,2006